Current stimulation device

The current stimulation device addresses electrolysis issues by controlling electrode connections through a shunt circuit, ensuring safe and efficient treatment while reducing costs and maintaining electrode lifespan.

JP7948592B2Active Publication Date: 2026-11-11ITO CO LTD
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
JP2022169441
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-10-21
Publication Date
2026-11-11
Estimated Expiration
2042-10-21

AI Technical Summary

Technical Problem

Existing current stimulation devices face issues with electrolysis of electrode materials due to residual charges, leading to skin damage, reduced adhesive strength, and increased costs, as well as decreased treatment efficiency and lifespan of electrodes.

Method used

A current stimulation device with a control unit that selectively controls the connection between electrodes using a shunt circuit to manage residual charges, preventing electrolysis and ensuring safe and efficient treatment by connecting electrodes directly or indirectly based on the type of treatment current.

Benefits of technology

Prevents skin damage and electrode deterioration, maintains treatment efficiency, and reduces costs by effectively managing electrolysis and residual charges, thereby extending the lifespan of electrodes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007948592000001
    Figure 0007948592000001
  • Figure 0007948592000002
    Figure 0007948592000002
  • Figure 0007948592000003
    Figure 0007948592000003
Patent Text Reader

Abstract

To provide a current stimulation device that applies an electrical stimulation, the device having functions of suppressing degradation of a surface coat layer of an electrode for applying current, preventing malfunction in a skin surface, improving treatment efficiency, and suppressing treatment costs.SOLUTION: A current stimulation device according to the present invention that applies an electrical stimulation includes: a plurality of output terminals to which a plurality of electrodes that outputs a treatment current for applying the electrical stimulation is connected; a cable that connects the electrodes and the output terminals; a waveform generation unit that generates the treatment current; and a control unit that controls the waveform generation unit. The waveform generation unit includes a circuit unit that connects the output terminals when the electrical stimulation is not output. The connection is performed for each pulse forming the treatment current.SELECTED DRAWING: Figure 3
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a current stimulation device used in physical therapy for applying current stimulation to the skin surface of a human body or percutaneously.

Background Art

[0002] Conventionally, various devices for applying stimulation to the skin surface of the human body have been proposed for the purposes of obtaining cosmetic effects, relieving muscle stiffness and fatigue, or for treatments such as pain relief, muscle tension relief, and tissue repair. For example, as devices that apply current stimulation via electrical signals as stimulation, there are therapeutic devices that obtain therapeutic effects such as pain relief and motor function improvement by supplying low-frequency electrical signals to living bodies, and so-called EMS (Electrical Muscle Stimulation) devices that provide exercise effects through muscle stimulation. In addition, as current stimulation, there are various methods such as percutaneous electrical stimulation, high voltage stimulation (high voltage), and microcurrent, which have different effects on each living body, and these methods are selected according to various purposes such as treatment and beauty care.

[0003] For example, Patent Document 1 relates to a current stimulation therapeutic device that causes a weak current to flow to a wound site through an electrode in order to promote wound healing, and discloses a technology that includes a mechanism for causing a pulsed current of a square wave to flow repeatedly at a constant cycle and shunting the anode and the cathode after the electrical stimulation ends. This is intended for the effect that fibroblasts, which form the basis of granulation tissue that serves as the bud for tissue regeneration, move to the cathode side due to the shunt, thereby promoting wound healing.

Prior Art Documents

Patent Documents

[0004]

Patent Document 1

Summary of the Invention

Problems to be Solved by the Invention

[0005] Patent Document 1 describes a method in which a unipolar pulse is repeatedly used as the current used for treatment (hereinafter referred to as the treatment current), and a shunt is performed after the treatment is completed. In this case, negative charges appear to accumulate on the anode side and positive charges on the cathode side for the duration of the treatment. On the other hand, pad-type electrodes are used in such current stimulation devices, and in addition to metal materials, electrolytes such as conductive gel are used in the surface coating layer. Here, it has been revealed that the treatment current causes electrolysis of the compounds and electrolytes constituting the electrodes at each electrode, for example, in the conductive gel on the surface, due to the charges accumulated in the materials constituting the electrodes and in the human body (hereinafter referred to as residual charges). The electrolytic products produced by electrolysis cause the pH value to change, with the acidity increasing on the anode side and the alkalinity increasing on the cathode side. This phenomenon can alter the electrode surface coating layer, and it is conceivable that inflammation or burns or other damage may occur on the skin surface in contact with the electrodes due to acid or alkali. In other words, damage to the skin surface due to electrochemical action is a problem.

[0006] Electrodes and conductive components used in such electrical stimulation, which come into contact with the human body to provide therapeutic current, or components comprising such electrodes and conductive components, are called electrodes. Such problems due to residual charge are not limited to the conductive gel that comes into direct contact with the skin, but can also occur in various materials that make up pad-type electrodes. For example, they can occur in conductive adhesives used in electrodes or in coating layers that coat conductive components, causing problems such as reduced adhesive strength or deterioration and peeling of the coating layer, leading to a deterioration in the performance and shortening of the lifespan of the electrodes. Products generated in the components and materials that make up the electrodes, or in substances that come into contact with the human body such as the conductive gel mentioned above, may also act on other components and materials where the above-mentioned electrolysis did not occur, causing them to deteriorate and have other adverse effects. In such conditions, the desired therapeutic current is not properly supplied to the human body, resulting in problems such as insufficient treatment and reduced treatment efficiency. For this reason, measures such as selecting materials that are not affected by residual charge or replacing electrodes early before reduced adhesive strength or peeling of the coating occurs were necessary, which led to increased costs for electrodes and treatment. [Means for solving the problem]

[0007] To solve the aforementioned problems, the current stimulation device according to the present invention is a current stimulation device that applies electrical stimulation, comprising: a plurality of output terminals to which a plurality of electrodes that output a therapeutic current for applying the electrical stimulation are connected; a cable connecting the plurality of electrodes and the plurality of output terminals; a waveform generation unit that generates the therapeutic current; and a control unit that controls the waveform generation unit. The electrode has a conductive adhesive layer on its surface. The waveform generation unit includes a circuit unit that connects the output terminals when the electrical stimulation is not output. The control unit selectively changes the timing of connection between the output terminals by the circuit unit according to the type of treatment current output, and when a unipolar pulse is selected as the treatment current, The therapeutic current is composed of individual pulse Each time the output is generated, the control that executes the aforementioned connection is performed. It is characterized by the following:

[0008] Furthermore, the control unit, If a bipolar pulse is selected as the treatment current, the connection will not be made for each pulse, and the connection between the output terminals will be made after the output of the treatment current has stopped. It is characterized by its ability to control. [Effects of the Invention]

[0009] The present invention, having the above configuration, enables the function of electrically connecting the electrodes used for each pulse output, either directly or indirectly, when using unipolar pulses. This suppresses the electrolysis of the coating layer and conductive electrolyte used in the electrodes, thereby preventing skin damage such as burns caused by acidic or alkaline components, or deterioration of the electrodes themselves due to adverse effects.

[0010] Furthermore, by avoiding malfunctions in the electrodes and preventing a decrease in treatment efficiency, and by increasing the options for components and materials used in the electrodes, it is possible to prevent an increase in the cost of the electrodes, as well as prevent a decrease in the lifespan of the electrodes and thus avoid an increase in treatment costs. [Brief explanation of the drawing]

[0011] [Figure 1] This is a diagram showing the configuration of an electric current stimulation device according to an embodiment of the present invention. [Figure 2] This is a block diagram of the main body of an electrical stimulation device according to an embodiment of the present invention. [Figure 3]This diagram illustrates the output current and operating timing of the shunt function of an embodiment of the present invention. [Figure 4] This is an explanatory diagram illustrating the operation of the current stimulation device according to an embodiment of the present invention when a positive polarity pulse is used as a therapeutic current. [Figure 5] This is an explanatory diagram of the operation when a negative polarity pulse is used as a therapeutic current in the current stimulation device according to an embodiment of the present invention. [Figure 6] This is a circuit diagram showing an example of a circuit that realizes the shunt function of the current stimulation device according to an embodiment of the present invention. [Figure 7] This is a circuit diagram showing another example of a circuit that realizes the shunt function of the current stimulation device according to an embodiment of the present invention. [Figure 8] This is an explanatory diagram illustrating the operation of the shunt function control in the current stimulation device according to the second embodiment of the present invention. [Figure 9] This is an explanatory diagram illustrating the operation of the physical therapy device according to the second embodiment of the present invention when both unipolar and bipolar pulses are used as therapeutic currents. [Figure 10] This is an explanatory diagram illustrating the operation of a current stimulation device according to a second embodiment of the present invention when a bipolar pulse of a different waveform is used as the therapeutic current. [Modes for carrying out the invention]

[0012] (First embodiment) Embodiments of the present invention will be described below with reference to the drawings. Figure 1 shows the current stimulation device 1 of the present invention, which consists of a main body 11, a pair of electrodes 12, and a connecting cable 13. The main body 11 generates a therapeutic current that provides the electrical stimulation necessary for treatment, and has a function to control the therapeutic current by parameters such as the amplitude, waveform, and supply time of the therapeutic current. The electrodes 12 are generally pad-type electrodes so that electrical stimulation can be supplied to the part of the human body that requires treatment (hereinafter referred to as the treatment site). A conductive gel is applied to the pad-type electrodes to ensure conductivity and to fix the pad to the treatment site with its adhesive force. The main body 11 and the electrodes 12 are connected by a connecting cable 13. The description shows a case where the electrodes 12 consist of one pair of pad-type electrodes, but it is not limited to this, and may consist of three or more pad-type electrodes, or there may be multiple pairs of them. Alternatively, a configuration in which multiple pairs of one pair of electrodes 12 are used may also be used.

[0013] Figure 2 is a block diagram illustrating the main unit 11. The main unit 11 comprises a waveform generation unit 111, a control unit 112, and a user interface unit (user IF unit) 113. A pair of electrodes 12 are connected to the main unit 11 by a connecting cable 13 connected to output terminals A14 and B15. In the user interface unit 113, the user sets the waveform, intensity, treatment time, etc., of the treatment current and transmits each setting value to the control unit 112. Based on these setting values, the control unit 112 instructs the waveform generation unit 111 to generate electrical stimulation that will become the treatment current. The waveform generation unit 111 generates a treatment current waveform according to the setting values ​​set in the user interface unit 113, following the instructions from the control unit 112. The treatment current is supplied to the treatment site by the electrodes 12 through the connecting cable 13 from output terminals A14 and B15.

[0014] The waveform generation unit 111 generates an output current I of a unipolar pulse as shown in Figure 3 as a therapeutic current. The output current I is composed of a plurality of rectangular pulses. When the absolute value of the current is simply referred to as the current value in the present specification, the output current I has a state with a large current value and a state with a small current value, the state with the large current value is referred to as High, and conversely, the state with the small current value is referred to as Low. When the output current I, which is a unipolar pulse as shown in Figure 3, becomes Low, that is, when the absolute value of the current of the output current I (hereinafter described as "current value" or the like) becomes small or zero, the output terminal A14 and the output terminal B15 are electrically connected directly or indirectly as described later (hereinafter described as "shunting" or the like), and as a result, the function of discharging or neutralizing the charge accumulated between the pair of electrodes 12 operates, shunting is performed for each pulse so that shunting is not performed at the time of High, which is represented by ON / OFF of the shunt function in Figure 3. As will be described later, this operation is realized in the waveform generation unit 111 using the output current I of the unipolar pulse for treatment.

[0015] In order to realize the operation of Figure 3, in the waveform generation unit 111, as shown in Figure 4, the shunt operation using the therapeutic current, which is the output current I, is realized using a switching element. The part that realizes this operation is a circuit unit, which is hereinafter referred to as a shunt circuit. As shown in Figure 4, when the input positive pulse is High, it is turned OFF, and the output terminal A14 and the output terminal B15 are shunted, that is, when the space between the pair of electrodes 12 is shunted and the output current I is Low (0V), the shunt circuit A41 using a switching element of a polarity that turns ON so as to release the accumulated charge, that is, the residual charge, can be realized with one element. In this case, since the switching element is turned ON except when the pulse of the therapeutic current is High, the space between the electrodes is shunted, and the potential between the electrodes can be maintained at the same potential. On the other hand, when the input is a negative pulse, as shown in Figure 5, it is turned ON so as to release the accumulated charge when it is High (0V), that is, when the current value which is the absolute value of the output current I is small or zero, and a shunt circuit B51 using a switching element of a polarity that turns OFF at the time of Low may be used.

[0016] Unipolar pulses are repeatedly used as therapeutic current, and shunting is performed after the treatment is completed. In this case, negative charges apparently accumulate on the anode side and positive charges apparently accumulate on the cathode side by the duration of the treatment. On the other hand, pad-type electrodes are used in such a current stimulation device, and in addition to a metal material as the material thereof, an electrolyte such as a conductive gel is used for the surface coating layer. Here, it has been clarified that due to the therapeutic current, electrolysis of the compounds constituting the electrodes and the electrolyte occurs, for example, in the conductive gel on the surface, due to the charges accumulated in the members constituting each electrode and the human body (hereinafter referred to as residual charges), and the electrolytic products generated by the electrolysis cause the pH value to change, such that the acidity increases on the anode side and the alkalinity increases on the cathode side. This phenomenon may alter the properties of the electrode surface coating layer, and disorders such as inflammation and burns caused by acid or alkali may occur on the skin surface in contact with the electrode. That is, damage to the skin surface due to electrochemical action poses a problem.

[0017] Electrodes and conductive members used for such current stimulation, which come into contact with the human body to provide therapeutic current, or those configured to include the electrodes or conductive members, are referred to as applicators. Such problems caused by residual charges may occur not only in the above-mentioned conductive gel that directly contacts the skin, but also in various materials constituting the pad-type electrodes. For example, it also occurs in the conductive adhesive used for the applicator or the coating layer that coats the conductive member, causing problems such as reduced adhesive strength and deterioration and peeling of the coating layer, leading to performance degradation and shortened service life of the applicator. Products generated in the members and materials constituting the electrodes, or in substances that come into contact with the human body such as the above-mentioned conductive gel, may act on other members and materials where the above-mentioned electrolysis has not occurred, and may cause adverse effects such as deteriorating these members and materials. In such a state, a desired therapeutic current cannot be appropriately supplied to the human body, and a problem of reduced treatment efficiency has occurred, such as failure to obtain sufficient treatment. For this reason, countermeasures such as selecting materials that are not affected by residual charges or replacing the applicator early before the decrease in adhesive strength or coating peeling occurs are required, which induces an increase in the cost of the applicator and treatment.

[0018] This configuration prevents electrolysis of the conductive adhesive, coating layer, or conductive gel used in the electrodes when a unipolar pulse is used as the therapeutic current, thereby preventing burns and other injuries. Furthermore, it prevents increased costs for the electrodes 12, maintains their lifespan, and prevents a decrease in treatment efficiency.

[0019] Furthermore, by incorporating the above-mentioned shunt circuit, the shunt function operates from before the start of treatment, when a unipolar pulsed therapeutic current is applied, until after treatment. Except when the therapeutic current is flowing, the pair of electrodes 12 are always electrically connected, directly or indirectly, and at the same potential. This also suppresses the generation of static electricity due to the accumulation of charge between the electrodes 12, enabling safe treatment.

[0020] Figure 6 shows the implementation of the operating function described in Figure 4 as a specific circuit configuration. Among the circuits constituting the waveform generation unit, the output circuit that realizes the shunt operation for each pulse when the unipolar pulse is a positive pulse is shown as the shunt circuit C61. In accordance with the positive pulse input Ip from the control unit, the output of Vcc appears as a positive unipolar pulse output at electrode 12 by a switching circuit consisting of transistor B615, transistor C617, and resistor B616. Here, the positive pulse input Ip from the control unit is first delayed by a time constant by a delay circuit 62 consisting of resistor C618 and capacitor 619, then inverted by an inverting element 611 in the shunt circuit C61, and input to the base of transistor A612, which is a switching element that performs the shunt. Therefore, when the positive electrode pulse input Ip is High, transistor A612 is OFF, and Vcc appears directly as an output on the electrode 12 side. When the positive electrode pulse input Ip is Low, transistor A612 is ON, the output on the electrode side is connected to GND, and the accumulated charge is discharged or neutralized. The circuit that realizes the shunt operation may be configured to connect the electrodes 12 directly or indirectly via ground, but a protection circuit may be provided as a protective measure to prepare for unforeseen circumstances. For example, in the shunt circuit C61 in Figure 6, a resistor A613 is provided as a protective resistor rather than simply shorting, as shown in the figure. In addition, a protection diode A614 is provided that prioritizes output ON to prevent component damage or loss of power due to simultaneous ON of output and discharge. By providing such a protection circuit, it is possible to reliably discharge the charge while protecting the element. In other words, the pair of electrodes 12 are connected directly by a switching element or indirectly via a protection circuit or protective measure. A switching element that shunts a pair of electrodes 12 in this way is called a shunt switching element. In Figure 6, transistor A612 corresponds to the shunt switching element. In the circuit configuration of Figure 6, transistors C617 and A612, which are switching elements that turn the Vcc current on and off, will switch simultaneously if there is no inverting element 611.To achieve this, an inverting element 611 is used to control the on / off operation of transistors C617 and A612 in opposite directions. However, the present invention is not limited to this, and a transistor that switches in the opposite direction to transistor C617 in the circuit configuration may be used instead of transistor A612 in Figure 6 as the switching element for shunting. For example, both could be PNP transistors. A transistor that switches in the opposite direction in the circuit configuration turns on when the positive electrode pulse input Ip is low, so a separate inverting element 611 is not required, which is effective in simplifying the circuit configuration. Furthermore, in Figure 6, Vcc is supplied to the electrode 12 as the treatment current, but an amplifier that boosts or buckes Vcc can also be used as the treatment current. Alternatively, instead of using transistor C617 to switch the treatment current on and off and supply the treatment current, the treatment current may be supplied using PWM or the like, which can arbitrarily create the output current. In this case, the shunt of the present invention can be executed by inputting a signal obtained by stepping down or stepping up the treatment current, such that the shunt turns off when the treatment current is high and turns on when the treatment current is low, intoverting it if necessary, to the base of the transistor, which is the switching element that executes the shunt.

[0021] In the case of multiple pairs of electrodes, i.e., a multi-output channel configuration, it is necessary to prevent interference of the therapeutic current between each output during energization, and isolation is required for each channel. In this case, discharge must be performed in the output circuit, and isolation is required between the control signal of the discharge shunt circuit and the output circuit to maintain isolation. In Figure 7, a switching circuit element consisting of a transformer 712 and a transistor D715 switches the output of Vcc with a positive pulse input Ip from the control unit, and it appears as a positive unipolar pulse output to the electrodes 12 connected to output terminals A14 and B15. The shunt circuit D71 is realized as a shunt switching element by an optical device 711 alone or as a circuit part including the optical device 711, and isolation is maintained. Similar to Figure 6, a protective resistor D713 is provided, and a protective diode B714 is provided, which prioritizes output ON, in order to prevent component damage or a state of no energization when the output and discharge are turned ON simultaneously. By providing such a protective circuit, it is possible to reliably discharge or neutralize the charge while protecting the element. As described above, the on / off switching of the shunt element may be performed using the therapeutic current or a signal that generates the therapeutic current, such as a positive electrode pulse signal Ip. However, the present invention is not limited thereto, and the switching may be controlled by separately providing a signal that is at least synchronized with the therapeutic current and controls the switching element that performs the shunt.

[0022] (Second embodiment) In this embodiment, which is a different embodiment, the device configuration diagram in Figure 1 and the block diagram in Figure 2 are the same, but the configuration for controlling the shunt function is different. Unlike the first embodiment, in which the treatment current is used to switch the shunt circuit, the switching of the shunt circuit E81, which has a switching element as shown in Figure 8, is performed independently based on a switching control signal 82 from a separate control unit. In this case, it is possible to individually control the execution of the shunt function based on the type of treatment current, such as unipolar pulses and bipolar pulses. For example, when using unipolar pulses as shown in Figure 3, a control signal 82 should be supplied to the shunt circuit E81 such that the output terminal A14 and the power terminal B15 are electrically connected by the shunt circuit E81 in synchronization with the output current I becoming Low, so that the shunt is executed for each pulse. In Figure 8, assuming that the shunt circuit E81 uses a switching element in which the shunt is executed when the control signal is High, the control signal 82 used is a signal that is in opposite phase to the output current I. Conversely, if a switching element is used in which the shunt is executed when the control signal is Low, the control signal 82 can also be a signal that is in the same phase as the output current I.

[0023] For example, in cases where treatment is performed with unipolar pulses followed by bipolar pulses, as shown in Figure 9, unlike unipolar pulses, the alternating application of positive and negative charges to the electrodes in the case of bipolar pulses does not cause electrolysis, or if it does, it generates less residual charge than in the case of unipolar pulses, and the effects of residual charge are considered to be less. Therefore, shunting for each pulse, as in the case of unipolar pulses, is not necessary, and it is considered sufficient to perform shunting after the completion of treatment, for example, to promote wound healing. In such cases, while outputting unipolar pulses, the shunt circuit is controlled to operate for each pulse as in the first embodiment, and after outputting bipolar pulses, the shunt circuit is operated once.

[0024] In specific operation, as shown in Figure 9, when both unipolar and bipolar pulses are used, if the output current I of a unipolar pulse is output, the shunt circuit E81 performs a shunt for each pulse. If the output current I of a bipolar pulse is output, the shunt circuit E81 does not perform a shunt, and the shunt can be performed after treatment. If the shunt circuit E81 uses a switching element that executes a shunt when the control signal is High, then during treatment with the output current I of a bipolar pulse, the control signal 82 is kept Low, and after treatment, i.e., when the supply of the output current I is stopped, the control signal 82 becomes High. Conversely, if a switching element that executes a shunt when the control signal is Low is used, then during treatment with the output current I of a bipolar pulse, the control signal 82 is kept High, and after treatment, i.e., when the supply of the output current I is stopped, the control signal 82 becomes Low. Thus, when performing a shunt after treatment, the time from when the output current I stops until the shunt is executed (time T in Figure 9) can also be used as one of the parameters. Time T can also be defined as the elapsed time after the end of the treatment current output time, or after the output of the last pulse of the output current I. Time T may also be configured to be set separately by the user via the user interface unit 113.

[0025] In the second embodiment, the operation of such a shunt circuit can be controlled by an output pulse. Therefore, it is possible to accommodate devices that perform wound treatment using unipolar pulses, as well as devices with multiple functions, such as pain relief using bipolar pulse low-frequency current stimulation. In the case of such a current stimulation device with multiple functions, it is desirable for the control unit to switch between performing the shunt function each time, after the treatment is completed, or not performing it at all, depending on the pulse used.

[0026] More specifically, the shunt control performed by the control unit can be described as follows: no shunt, pulse-based shunt (as shown in Figure 3), post-treatment shunt (no shunt while the treatment current (output current I) is being output, but a shunt is performed after treatment), or periodic shunt (the treatment current is periodically stopped during treatment output to perform a shunt). If we refer to each of these as a shunt mode, then no shunt can be called the first shunt mode, the mode in which shunts are performed with each pulse can be called the second shunt mode, the mode in which shunts are not performed during treatment but only after treatment can be called the third shunt mode, and the mode in which shunts are performed periodically during treatment regardless of the pulse can be called the fourth shunt mode. The present invention is not limited thereto, and other shunt modes can also be described by parameters such as the timing of the shunt, i.e., when to perform the shunt, for example, information indicating the above-mentioned time T. Tomo A shunt mode can be used. In this embodiment, the user may select the shunt mode through the control signal 82 during treatment, or the shunt mode may be automatically switched according to the treatment method, i.e., the treatment current used. Alternatively, a combination of multiple shunt modes can be freely set. For example, if a unipolar pulse is selected for rehabilitation as shown in Figure 3, the control unit 112 may output a control signal 82 to the shunt circuit E81 to cause the shunt circuit E81 to execute the second shunt mode. Alternatively twin If a polar pulse is output, the control unit 112 may cause the shunt circuit E81 to execute the first shunt mode, that is, it may output a control signal 82 to the shunt circuit E81 that prevents shunting.

[0027] In addition, the shunt mode may be automatically set and executed depending on the specific treatment purpose. For example, even when outputting a unipolar pulse as shown in Figure 3, if the treatment current generates muscle contraction, the control unit 112 may automatically generate a control signal 82 that enables the execution of a second shunt mode, which is a shunt for each pulse, and send it to the shunt circuit E81 to execute a shunt for each pulse. On the other hand, even with a unipolar pulse as shown in Figure 3, if the current value does not cause muscle contraction, for example, in the treatment of pressure ulcers using a weak current, the shunt may be executed after treatment using a third shunt mode. Specifically, the user interface unit 113 may select a unipolar pulse, and if the output value exceeds a predetermined specific value, such as a threshold, the control unit 112 selects the second shunt mode, and if it does not exceed the threshold, the control unit 112 selects the third shunt mode, and supplies a control signal 82 to the shunt circuit E81 to execute the shunt corresponding to each shunt mode.

[0028] In Figure 9, a bipolar pulse is explained using an example where a positive current is immediately followed by a negative current, and then immediately by a positive current. In other words, a pulse train in which a positive High is followed by a negative High, followed by a positive High and a negative High is repeated is given as an example, but the present invention is not limited to this, and a pulse train like that in Figure 10 may also be used. That is, it may be a therapeutic current that uses pulses composed of a positive High, a negative High, and a Low repeatedly. In this case, the shunt may be performed after the output current I as in Figure 9, but it may also be performed when the output current I is Low. In the case of bipolar pulses, residual charge is less likely to occur, but if the resistance value has anisotropy with respect to the direction of the current depending on the material used for the electrodes and conductors, residual charge may be generated to some extent even with bipolarity, so it is more desirable to control the shunt at the timing when the output current I is Low. For example, the treatment current may consist of repeated pulses composed of negative High, positive High, and Low as bipolar pulses; or it may consist of repeated pulses composed of positive High, Low, and negative High; or it may consist of repeated pulses composed of negative High, Low, and positive High; or it may consist of repeated pulses composed of positive High, Low, negative High, and Low; or it may consist of repeated pulses composed of negative High, Low, positive High, and Low; or it may be a control that performs a shunt when the current is Low. Such a shunt when the current is Low may be performed each time the current is Low, but if there are multiple pulses in a single pulse, the shunt may be performed at least one of them. In other words, the control may be such that a shunt is performed at at least one of the states in which the treatment current is Low while the treatment current is being output or during treatment. Furthermore, while Figure 10 shows an example where the output current I is shunted for as long as it remains low once it goes low, the present invention is not limited to this example, and control may be implemented such that the shunting occurs for, for example, 50% of the time during which the output current I goes low.In other words, the control may involve shunting during at least a portion of the period when the therapeutic current is low, and repeating the shunting with each pulse while the therapeutic current is being output.

[0029] The control signal 82 described above typically uses a binary signal, High and Low. For example, the shunt is executed when the control signal 82 is High, but it may also be executed when the control signal 82 is Low, as long as the shunt is executed when the treatment current value is small or zero. However, an unexpected voltage may be generated between the pair of electrodes 12 immediately after the main unit 11 is powered on or off, after the treatment is finished and the treatment current output is stopped, or when used in an environment where static electricity is easily generated. In this case, the user may experience discomfort such as electrostatic discharge, which can cause problems. Alternatively, if the control unit 112 instructs the waveform generation unit 111 to stop the output due to an error in the main unit 11, but the waveform generation unit 111 malfunctions and the treatment current cannot be controlled, or if the control signal 82 is not output due to a failure of the control unit 112, an unexpected current may flow to the user, causing discomfort, or even burns due to the unexpected current. Therefore, it is desirable to use a switching element for the shunt that turns on when the control signal 82 is not High or when it is Low. In this configuration, even if static electricity is generated on the electrode 12 immediately before or after the power is turned on of the main unit 11, or if the main unit 11 malfunctions and the control signal 82 is not output, the shunt switching element turns on, shunting the pair of electrodes 12, preventing voltage from being generated between the pair of electrodes 12, and ensuring that no unexpected current flows to the user, thus realizing a safe and comfortable therapeutic device.

[0030] However, the shunt mode setting is not limited to this, and the control unit 112 may be configured to automatically set the shunt mode according to the treatment purpose. For example, when the user selects a treatment purpose such as rehabilitation, pressure ulcer treatment, or pain treatment from the user interface unit 113, the control unit 112 transmits parameters to the waveform generation unit 111 that specify the treatment current to be output, such as a unipolar pulse, a unipolar weak current, or a bipolar pulsed TENS. These parameters include information necessary to identify the treatment current to be used, such as the type of output treatment current (square wave, sine wave, etc.), frequency, pulse width, duty cycle, treatment time, and information on which of the above shunt modes to use. Depending on the shunt mode used, information such as the time and timing of the shunt and whether or not a shunt is necessary may also be included. The waveform generation unit 111 can output the treatment current and perform an appropriate shunt according to these parameters. Determining whether a shunt is necessary and when to execute it requires specialized knowledge. If the combination of therapeutic current and shunt mode is not appropriate, it can lead to malfunctions such as a failure to achieve the desired therapeutic effect and a decrease in treatment efficiency. For example, inducing muscle contraction with a unipolar pulse as shown in Figure 3 is suitable for rehabilitation as a treatment for paralysis. In this case, a second shunt mode is necessary, as the third and fourth shunt modes will cause the aforementioned problems due to residual charge. However, since the appropriate shunt mode is automatically selected according to the treatment purpose, a suitable therapeutic device can be provided that does not reduce treatment efficiency even without specialized knowledge of shunts.

[0031] Alternatively, the shunt mode may be set based on the output treatment current. The control unit 112 may be configured to automatically set the shunt mode according to the treatment current. For example, when a user selects a treatment current such as a unipolar pulse, bipolar pulse, weak current, or TENS displayed on the user interface unit 113, the control unit 112 transmits parameters to the waveform generation unit 111 that specify the treatment current to be output, such as a unipolar pulse, a unipolar weak current, or a bipolar pulsed TENS. These parameters include information such as frequency, pulse width, duty cycle, and treatment time, as well as which of the above shunt modes to use. The waveform generation unit 111 can output the treatment current and execute an appropriate shunt according to these parameters. Since specialized knowledge is required to determine whether a shunt is necessary and when to execute it, if the combination of treatment current and shunt mode is not appropriate, it can lead to problems such as not being able to obtain the desired treatment effect and a decrease in treatment efficiency. For example, inducing muscle contraction with a unipolar pulse as shown in Figure 3 is suitable for rehabilitation as a treatment for paralysis, but a second shunt mode is required for this purpose, as the third and fourth shunt modes cause problems due to residual charge as described above. However, since the appropriate shunt mode is automatically selected based on the treatment current, a suitable treatment device can be provided without reducing treatment efficiency, even without specialized knowledge of shunts.

[0032] In other words, the present invention, having the above configuration, enables efficient treatment by allowing the use of a shunt for each pulse, a shunt after treatment, and no shunt function for each pulse used, depending on the type of pulse (unipolar pulse and bipolar pulse) and the treatment purpose.

[0033] The above are merely preferred embodiments of the present invention, and the scope of protection of the present invention is not limited to the above embodiments. All equivalent improvements or modifications made by those skilled in the art based on the content disclosed herein are included in the claims of this application. For example, while the above mainly concerns electrical stimulation for wound healing and pain relief, it may also be combined with other electrical stimulations such as high voltage. To solve the aforementioned problems, the present invention provides a current stimulation device for applying electrical stimulation, comprising: a plurality of output terminals to which a plurality of electrodes that output a therapeutic current for applying the electrical stimulation are connected; a cable connecting the plurality of electrodes and the plurality of output terminals; a waveform generation unit for generating the therapeutic current; and a control unit for controlling the waveform generation unit, wherein the waveform generation unit includes a circuit unit for connecting the output terminals when the electrical stimulation is not output, and the connection between the output terminals is performed for each pulse constituting the therapeutic current. Furthermore, the control unit is characterized by selectively controlling the connection between the output terminals according to the therapeutic current. [Explanation of symbols]

[0034] 1 Current stimulator 11 Current stimulator main unit, main unit 12 electrodes 13. Cables, connecting cables 111 Waveform generator 112 Control Unit 113 User Interface Section 14 Output terminal A 15 Output terminal B 41 Shunt Circuit A 51 Shunt Circuit B 61 Shunt Circuit C 62 Delay Circuit 611 Inverting element 612 Transistor A 613 Resistance A 614 Diode A 615 Transistor B 616 Resistance B 617 Transistor C 618 Resistance C 619 Capacitor 71 Shunt Circuit D 711 Optical devices 712 Transformer 713 Resistance D 714 Diode B 715 Transistor D 81 Shunt Circuit E 82 Control signals

Claims

1. An electrical stimulation device that applies electrical stimulation, Multiple output terminals to which multiple electrodes that output the therapeutic current that provides the aforementioned electrical stimulation are connected, A cable connecting the plurality of electrodes and the plurality of output terminals, A waveform generation unit that generates the aforementioned therapeutic current, The system includes a control unit that controls the waveform generation unit, The electrode has a conductive adhesive layer on its surface. The waveform generation unit includes a circuit unit that connects the output terminals when the electrical stimulation is not output. The current stimulator is characterized in that the control unit selectively changes the timing of connection between the output terminals by the circuit unit according to the type of treatment current to be output, and when a unipolar pulse is selected as the treatment current, it performs control to execute the connection each time an individual pulse constituting the treatment current is output.

2. The current stimulation device according to claim 1, characterized in that, when a bipolar pulse is selected as the treatment current, the control unit controls the connection between the output terminals to be made after the output of the treatment current has stopped, without making a connection for each pulse.

Citation Information

Patent Citations

  • Skin bonding type electric stimulation device kit

    JP1988317164A

  • Absorbent for nitrogen oxide and sulfur oxide and its production

    JP1989176449A

  • Methods and apparatus for measuring neural responses

    JP2014522261A

  • Deposition method, deposition device and storage medium

    JP2015177106A

  • Electric stimulation treatment tool

    JP2016055178A